期刊文献+

沙丁胺醇多克隆抗体的制备及间接ELISA方法的建立 被引量:3

Preparation of salbutamol polyclonal antibodies and development of indirect competitive enzyme-linked immunoassay
下载PDF
导出
摘要 目的:制备特异性好的沙丁胺醇多克隆抗体,优化并建立间接ELISA快速检测沙丁胺醇(SAL)浓度的方法。方法:采用小剂量长周期的方式免疫新西兰大白兔,优化ELISA检测方法,检测一系列SAL浓度,建立标准曲线,并对方法的精密度和回收率进行测定。结果:所制备的沙丁胺醇多克隆抗体的IC50为12.21 ng/ml,建立了间接ELISA检测SAL浓度的标准曲线,样本的回收率在95%~105%之间,变异系数﹤3%。结论:本研究建立了快速、灵敏的间接ELISA检测SAL浓度的方法。 Objective: To prepare the antibodies against salbutamol (SAL) with high sensitivity and to develop an indirect competitive enzyme-linked immunoassay (ic-ELISA) for fast detection of SAL. Methods: The New Zealand white rabbits were immunized with SAL in a small close and long period mode. The method of ie-ELISA was optimized and adopted for the detection of a series of SAL samples, then the standard curve of SAL was established. The precision and the recoveries of the method were determined. Results: The antibodies with high sensitivity towards SAL were prepared with a IC50 of 12.21 ng/ml. The ie-ELISA method for SAL measurement was established, the recoveries of measurement was between 95% - 105% and the CV was 〈 3%. Conclusions: The antibodies against salbutamol have been prepared and an indirect competitive enzyme-linked immunoassay for fast and specific detection of SAL has been developed.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2013年第1期19-24,共6页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省重大科技专项基金(2010C13006) 浙江省卫生科研基金(2011KYA044)
关键词 沙丁胺醇 酶联免疫吸附测定 佐剂 免疫 抗体 多克隆 分析 Albuterol Enzyme-linked immunosorbent assay Adjuvants, immunologic Antibodies,polyclonal/analysis
  • 相关文献

参考文献15

二级参考文献134

共引文献72

同被引文献39

  • 1王自良,王建娜,张海棠,王选年,杨艳艳,张改平.苯巴比妥单克隆抗体的研制及竞争ELISA血药浓度监测方法的建立[J].中国药学杂志,2006,41(23):1826-1830. 被引量:4
  • 2张建群,杨扬,王艺熹,张铭,裘霁,郑晓冬.β-肾上腺素受体激动剂莱克多巴胺兔单克隆抗体的制备[J].农业生物技术学报,2007,15(3):398-403. 被引量:4
  • 3Kern C, Meyer T, Droux S, Schollmeyer D, Miculka C. Journal of Medicinal Chemistry, 2009, 52( 6): 1773-1777.
  • 4中华人民共和国 农牧发(1997)3号. 关于严禁非法使用的兽药通知.
  • 5Eaton E A, Walle U K, Wilson H M, Aberg G, Walle T. British Journal of Clinical Pharmacology, 1996, 41: 201-206.
  • 6Mareck U, Guddat S, Schwenke A, Beuck S, Geyer H, Flenker U, Elers J, Backer V, Thevis M, Sch?nzera W. Drug Testing and Analysis, 2011, 3: 820-827.
  • 7Domínguez-Romero J C, García-Reyes J F, Martínez-Romero R, Martínez-Lara E, Del Moral-Leal M L, Molina-Díaz A. J. Chromatogr. B, 2013, 923-924: 128-135.
  • 8Montrade M P, Le Bizec B, Monteau F, Andre F. Food Addit. Contam., 1995, 12(5): 625-636.
  • 9Joyce K B, Jones A E, Scott R J, Robert A. Biddlecombe and Stephen. Rapid Commun. Mass Spectrom., 1998, 12: 1899-1910.
  • 10Brambilla G, Di Bez S, Pietraforte D, Minetti M, Campanella L, Loizzo A. Anal. Chim. Acta, 2007, 586(1-2): 426-431.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部